Acute Hyperammonemia in Children Under Deferasirox Treatment: Cutting the Gordian Knot
Overview
Affiliations
Garcia-Farina B, Rink L, Santarini V, Westkemper M, Dohna-Schwake C, Mohlendick B Front Pharmacol. 2024; 15:1477755.
PMID: 39508042 PMC: 11538451. DOI: 10.3389/fphar.2024.1477755.
Deferasirox-induced hyperammonemia and Fanconi syndrome: a case report.
Zhou H, Xiong D, Feng Y, Jiang J Front Pediatr. 2024; 12:1461867.
PMID: 39449753 PMC: 11499891. DOI: 10.3389/fped.2024.1461867.
Quo vadis ureagenesis disorders? A journey from 90 years ago into the future.
Haberle J, Siri B, Dionisi-Vici C J Inherit Metab Dis. 2024; 47(6):1120-1128.
PMID: 38837457 PMC: 11586591. DOI: 10.1002/jimd.12763.
Kidney Tubular Damage Secondary to Deferasirox: Systematic Literature Review.
Scoglio M, Cappellini M, DAngelo E, Bianchetti M, Lava S, Agostoni C Children (Basel). 2021; 8(12).
PMID: 34943300 PMC: 8700300. DOI: 10.3390/children8121104.
Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male.
Fraser J, Brook R, He T, Lewis D BMJ Case Rep. 2020; 13(7).
PMID: 32646935 PMC: 7351284. DOI: 10.1136/bcr-2020-234542.